Focus Rheums| ACR Convergence 2024 Previews

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Study Probes Corticosteroid Dependence in Polymyalgia Rheumatica

Vivekanand Tiwari, MD, Emily Campbell, MD, Joshua Skydel, MD, Bryan Savage, MD, Monica Dimambro, Todd MacKenzie, PhD, & William F. Rigby, MD  |  

The Study Abstract

Presented at ACR Convergence 2023

Tiwari V, Campbell E, Skydel J, et al. Exploring the clinical characteristics and correlation with corticosteroid dependence in polymyalgia rheumatica (PMR) patients: Insights from an academic center [abstract]. Arthritis Rheumatol. 2023;75(suppl 9).

Disclosures

V. Tiwari: none; E. Campbell: none; J. Skydel: none; B. Savage: none; M. Dimambro: none; T. Mackenzie: none; W. Rigby: none.

ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Floris A, Piga M, Chessa E, et al. Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: A systematic literature review and meta-analysis. Clin Rheumatol. 2022;41:19–31.
  2. Hernández-Rodríguez J, Cid MC, López-Soto A, et al. Treatment of polymyalgia rheumatica: A systematic review. Arch Intern Med. 2009 Nov 9;169(20):1839–1850.
  3. Tiwari V, Devalla V, Campbell E, Rigby W. Trends in the cumulative exposure to corticosteroids in polymyalgia rheumatica (PMR) patients: A single academic center experience [abstract]. Arthritis Rheumatol. 2022;74(suppl 9).
  4. Kremers HM, Reinalda MS, Crowson CS, et al. Relapse in a population based cohort of patients with polymyalgia rheumatica. J Rheumatol. 2005 Jan;32(1):65–73.
  5. Albrecht K, Huscher D, Buttgereit F, et al. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database. Rheumatol Int. 2018 Apr;38(4):569–577.

Related Articles

    How to Manage Polymyalgia Rheumatica

    Recognizing the need to provide guidance on the current disparate management of polymyalgia rheumatica (PMR), the American College of Rheumatology (ACR), in collaboration with the European League Against Rheumatism (EULAR), recently published the first international set of recommendations for the screening, treatment and management of PMR.1,2 Specifically, the recommendations offer guidance on the use of…

    New Osteoarthritis Recommendations and Classification Criteria for Sjögren’s Syndrome and Polymyalgia Rheumatica

    The ACR has published three documents intended to provide clarity and consensus on management of osteoarthritis, classification criteria for Sjögren’s syndrome, and classification criteria for polymyalgia rheumatica. The documents, which represent the most current clinical evidence, research, and expert panel input and review, can help inform clinical practice and provide clearer target populations for future research.